Department of Urology

Institute for Prostate Cancer Research (IPCR)

Devising therapies and new technologies in hopes of one day finding a cure

The Institute of Prostate Cancer Research (IPCR) is a collaborative effort of Fred Hutchinson Cancer Research Center and UW Medicine. A natural outgrowth of established research and clinical collaborations, the IPCR brings together a world-renowned team whose mission is to understand the causes of prostate cancer and its progression, develop new prevention strategies, devise innovative diagnostics and improve survival and quality of life

Professor and Chair Emeritus Dr. Paul Lange spent considerable effort to establish the IPCR, which supports research activities of approximately 15 programs at UW and Fred Hutch. Together these researchers have already identified and/or assembled up to 80 percent of the genes expressed in prostate cancer, developed one of the largest serum and tissue banks in the world, undertaken some of the most advanced studies of bone biology and skeletal metastases, assembled information and genotypes for more than 300 families with hereditary prostate cancer, and developed many new therapeutic strategies.

Professor of Urology Daniel Lin, MD, is the Director of the IPCR.